Tonix Pharmaceuticals Holding (TNXP) Current Deferred Revenue (2012 - 2026)
Tonix Pharmaceuticals Holding's Current Deferred Revenue was $3.82 million in Q2 2026, up 26.9% from $3.01 million a year earlier but down 9.7% from the prior quarter.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Current Deferred Revenue (2012 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Tonix Pharmaceuticals Holding came in at $3.43 million, up 88.6% from FY2024.
- Current Deferred Revenue shows a three-year compound annual growth rate of 1.5% (FY2022 to FY2025).
- In earlier years, Current Deferred Revenue was $1.82 million in FY2024 (-39.1%), $2.98 million in FY2023 (-9.0%) and $3.27 million in FY2022.
- Quarterly Current Deferred Revenue has moved between $1.82 million (Q4 2024) and $4.23 million (Q1 2026) over five years.
- Compared with a year earlier, Current Deferred Revenue has increased for three straight quarters, with growth averaging 48.8% over the last four quarters.
- Per Business Quant data, TNXP's Current Deferred Revenue in the three quarters before Q2 2026 was $4.23 million (Q1 2026), $3.43 million (Q4 2025) and $2.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Tonix Pharmaceuticals Holding | 163.56 Mn | 163.56 Mn | 12.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Dec 31, 2022 | 3.27 Mn |
| Dec 31, 2012 | 3,155.00 |
API Access
Tonix Pharmaceuticals Holding Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();